Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
23
2020
K&L Gates Triage: Recent Developments in the 340B Drug Pricing Program [Podcast] K&L Gates
Sep
10
2020
K&L Gates Triage: Rutledge v. Pharmaceutical Care Management Association [Podcast] K&L Gates
Feb
15
2021
Chancery Court Enforces Merger Agreement Milestone Payment Despite Time and Cost to Bring Experimental Drug to Market K&L Gates
Aug
3
2022
What The Fudge?! Popular Breakfast Snack’s Lack Of Key Ingredient Did Not Trigger Liability Under State Consumer Fraud And Magnuson-moss Warranty Acts K&L Gates
Nov
4
2019
In The Weeds: Key Intellectual Property Takeaways For The Cannabis Industry K&L Gates
Jan
23
2020
Medical Marijuana Protections Continue to Expand in New Jersey K&L Gates
Dec
8
2016
What a Trump Administration Could Mean for the 340B Drug Program K&L Gates
Aug
27
2020
K&L Gates Triage: Q&A: What Sponsors and Investigators Need to Know about FDA’s ClinicalTrials.gov Reporting Requirements [PODCAST] K&L Gates
Jul
1
2021
More than Innovation and Competition: The Latest Proposed Monitoring and Enforcement Mechanisms Targeting Foreign Influence in U.S. Research K&L Gates
Jul
8
2021
340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case K&L Gates
Jul
15
2018
In the Weeds: Navigating the Shifting Federal Regulation of Medical Marijuana K&L Gates
Aug
17
2022
Wine Labelling: A New EU Regulation Is Coming Into Force in 2023 K&L Gates
Jan
5
2023
Breakthrough FDA Decision: Agency Completes Its First Pre-Market Consultation for Human Food Made from Cultured Animal Cells K&L Gates
Apr
1
2020
Court Of Chancery Orders Specific Performance Of Merger Agreement, Finding That Fraud Contained In FDA Filings For Approval Of Target Product Did Not Rise To A “Material Adverse Effect” K&L Gates
Sep
20
2023
Ninth Circuit Finds that Costco Is Not Just a Retailer, but Actively Competes with Wholesalers with Respect to Robinson-Patman Price Discrimination Claims K&L Gates
Jan
18
2017
340B Update: HRSA Finalizes 340B Pricing & Penalties for Drug Manufacturers K&L Gates
Apr
23
2024
Litigation Minute: The Lifecycle of Beauty Packaging K&L Gates
Jul
19
2017
Protecting Plant Innovations: Patents in United States, Australia, and New Zealand K&L Gates
Jul
15
2019
Beauty And The Beast – A Tale Of (Trade Mark Infringement) As Old As Time K&L Gates
Apr
23
2020
COVID-19: IP Strategies for Universities and Nonprofits During the Pandemic – Mitigating Patent Infringement Risks When Making PPE and Other Health-Related Supplies K&L Gates
May
1
2020
COVID-19: Labs Beware! – EKRA Expands DOJ’s Enforcement Arsenal in the COVID-19 Fraud Battle K&L Gates
Jun
26
2020
Market Entry and Real World Data – China’s Medical Device Industry K&L Gates
Feb
8
2024
Fraud May Not Always Unravel All–What Does the Contract Say? K&L Gates
Dec
2
2020
OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees K&L Gates
Mar
23
2021
First Cannabis-Related Business SARS Penalty Against a Depository Institution K&L Gates
May
7
2021
HHS Exemptions for Buprenorphine (But not Methadone) Prescribers K&L Gates
Jun
21
2018
Chocolate Slab-Gate K&L Gates
Jul
29
2019
The Scotch Whisky Saga: Where Name And Reputation Is Not Enough K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins